{"filings":[{"id":97328,"accession_number":"0001213900-26-052324","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"DMAA SPAC signs $1B deal to merge with AI/analytics firm Power Analytics Global","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Definitive merger agreement with Power Analytics Global (PAGC) at target enterprise value of $1.0B; floor of $300M.","Post-close ownership: ~90% to PAGC shareholders, ~10% to existing DMAA shareholders pre-PIPE dilution.","Minimum cash target at closing of $30M (floor $15M) from trust account and/or PIPE financing.","Merger subject to DMAA shareholder approval, SEC S-4 effectiveness, and Nasdaq listing of surviving entity.","Two amendments on April 30, 2026 corrected governing law to Delaware and completed notice address provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97327,"accession_number":"0001213900-26-051018","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["5.03","5.07","8.01","9.01"],"status":"ready","headline":"SPAC DMAA shareholders approve extension to April 2027; ~28% of shares redeemed for $99.3M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Extension proposal approved: 18,906,281 for, 4,892,646 against, 0 abstain.","Combination period extended up to 12 months to April 29, 2027 with monthly deposits of ~$300k.","Redemption of 9,440,230 shares at ~$10.52/share, removing $99,336,016.67 from trust account.","Post-redemption shares outstanding: 24,276,913 (13,559,770 from IPO).","Board approved initial one-month extension to May 29, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97326,"accession_number":"0001213900-26-048585","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"DMAA updates CFO equity to 175k shares, sets CEO compensation terms, both tied to definitive deal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CFO Saleem Elmasri's share grant increased from 100k to 175k ordinary shares, earned upon signing a definitive agreement and issued at closing of initial business combination.","CEO Roger Bendelac receives 250k ordinary shares under same vesting trigger; monthly cash comp of $4,500 with up to $2,000 deferrable based on cash flow.","Monthly CFO fee unchanged at $3,500; unpaid amounts accrue as binding obligations; shares replace prior unissued 100k.","Compensation structures signal progress toward a business combination, though no definitive agreement announced as of April 28, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97325,"accession_number":"0001213900-26-041284","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"DMAA signs LOI for de-SPAC merger with Power Analytics Global Corp at ~$1B valuation","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Non-binding letter of intent signed April 7, 2026, with target Power Analytics Global Corp (Delaware).","Implied equity valuation of approximately $1.0 billion, subject to due diligence and adjustments.","Minimum cash condition expected in range of $25 million to $50 million, subject to redemptions.","Parties will negotiate definitive business combination agreement; deal to result in PAGC becoming public.","DMAA may seek stockholder approval to extend business combination deadline; sponsor support possible."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111984,"accession_number":"0001213900-26-035502","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["1.01","8.01","2.03","9.01"],"status":"ready","headline":"DMAA SPAC enters $100K convertible bridge as first step of $500K financing; identifies AI/cybersecurity target","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BV Advisory Partners provides $100K convertible note (up to $500K total) for compliance and transaction expenses.","Note converts at 35% discount to post-merger market value, matures in 6 months, no interest, no trust account claim.","Investor introduced potential target: enterprise AI/ML, quantum analytics, cybersecurity platform (Power Analytics Global).","Company to pursue replacement sponsor and provide investor ≥40% sponsor-level economics; no definitive agreement yet.","Proceeds used for audit, Nasdaq, legal, proxy, extension fees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111983,"accession_number":"0001213900-26-024762","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Drugs Made In America confirms trust account intact after affiliate irregularities","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sponsor made improper withdrawals from affiliate's working capital account between Sept 26, 2025 and Dec 31, 2025.","Board immediately acted; irregularities did not extend to the company's trust account.","As of March 6, 2026, trust account holds approximately $241,292,436.","No details on amount of irregularity or actions against sponsor disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111982,"accession_number":"0001213900-26-024392","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CEO Lynn Stockwell resigns after affiliate fund irregularities; Roger Bendelac appointed CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lynn Stockwell resigned as CEO, Executive Chair, and Board member of DMAA and affiliate, effective Feb 28, 2026.","Resignation followed board request after Sponsor withdrew ~$1.1M from affiliate's account, including ~$566K overpayment and $200K for unrelated expenses; Sponsor cannot repay.","Roger Bendelac appointed as new CEO; has 30+ years in investment banking/corporate advisory; compensation not yet determined.","Board removed Ms. Stockwell from all positions on Feb 28, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128610,"accession_number":"0001213900-25-111704","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CFO Glenn Worman resigns; Saleem Elmasri appointed as CFO of Drugs Made In America Acquisition Corp.","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Glenn Worman resigned as CFO and principal financial & accounting officer on Oct 8, 2025; no disagreement cited.","Saleem Elmasri appointed CFO effective Nov 17, 2025; will serve via Titan Advisory Services LLC.","Elmasri receives $42,000/year ($3,500/month) consulting fee and 100,000 ordinary shares upon engagement.","Elmasri is a CPA with 20 years experience, previously at PwC and as managing partner at Titan Advisory."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181662,"accession_number":"0001213900-25-016702","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["3.02","8.01","9.01"],"status":"ready","headline":"SPAC raises $30M via over-allotment; trust now $231.15M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Underwriters exercised over-allotment option in full on Feb 18, 2025; 3M additional units at $10/unit raised $30M.","Sponsor purchased 30K additional private placement units for $300K, bringing total private units to 430K.","Total trust account now holds $231.15M from IPO, over-allotment, and private placement proceeds.","1,285,714 founder shares are no longer subject to forfeiture due to over-allotment exercise.","Underwriters received 30K representative shares issued in connection with the over-allotment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181661,"accession_number":"0001213900-25-016602","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Drugs Made In America Acquisition Corp. announces separate trading of shares and rights starting Feb 25","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Effective Feb 25, 2025, holders of units (DMAAU) may separate into ordinary shares (DMAA) and rights (DMAAR).","Units not separated continue to trade on Nasdaq under DMAAU; separated shares and rights trade under DMAA and DMAAR.","Holders must contact VStock Transfer LLC via their broker to effect the separation; no fractional rights issued.","The company's IPO units were offered under registration statement effective Jan 7, 2025, with post-effective amendment Jan 27, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181660,"accession_number":"0001213900-25-010079","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Drugs Made In America Acquisition Corp. closes $200M IPO and $4M private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 20,000,000 units at $10.00 each raises $200,000,000 gross proceeds.","Sponsor purchased 400,000 private units for $4,000,000; $1,100,000 receivable noted.","Net proceeds of $201,000,000 deposited into trust account ($10.05 per public share).","Balance sheet shows $201M in trust, $6M deferred underwriting fees, and shareholders' deficit of $6.6M.","Going concern warning: working capital deficit of $555,420; company must complete a business combination within 15-21 months or liquidate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181659,"accession_number":"0001213900-25-008377","cik":2028614,"company_name":"Drugs Made In America Acquisition Corp.","ticker":"DMAA","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["1.01","3.02","5.03","8.01","9.01"],"status":"ready","headline":"Drugs Made In America Acquisition Corp. closes $200M IPO, deposits $201M in trust","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed IPO of 20,000,000 units at $10.00 per unit for gross proceeds of $200 million.","Simultaneous private placement of 400,000 units to sponsor for $4 million, bringing total trust to $201 million.","Units trade on Nasdaq under DMAAU; ordinary shares (DMAA) and rights (DMAAR) to trade separately later.","Clear Street acted as sole book-running manager; offering made under effective S-1 registration statement.","Underwriters have 45-day option for up to 3M additional units to cover over-allotments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":257335265.88124415,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}